The MS Board of Pharmacy (MSBOP) recently received communication from NABP regarding DEA’s policy on CII changes. MSBOP staff have verbally verified this policy with local DEA field staff leadership. Until DEA provides additional written policy, they will defer to the state’s policy on changes to a CII prescription. The MSBOP policy would allow changes to a CII prescription as outlined below:
